Novozymes A/S (OTCMKTS:NVZMF – Get Free Report) and Amyris (NASDAQ:AMRS – Get Free Report) are both basic materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, valuation, earnings, analyst recommendations and dividends. Profitability This table compares Novozymes A/S and Amyris’ […]
LanzaTech Global (NASDAQ:LNZA – Get Free Report) and Amyris (NASDAQ:AMRS – Get Free Report) are both small-cap business services companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, analyst recommendations, risk and dividends. Analyst Recommendations This is a summary of […]
The global Synthetic Biology Market is expected to be worth US$ 15.8 billion by the end of 2022, and to grow at a CAGR of 24.3% to be worth US$ 138.8 billion by 2032. According to a recent study by Future Market Insights, the oligonucleotides segment by product will lead the market with a share of approximately 43.6.